Transform your pharma business for a sustainable future
Pharmaceutical companies must transform their business models to be competitive in the changing healthcare ecosystem.
The future of healthcare will be defined by technologies (digitalization, AI, IoT, etc.), financial pressures, growing competition, and market changes with new patients and HCP needs that will impact traditional linear value creation and traditional business models.

Pharmaceutical companies will have to adapt quickly and find new opportunities by creating value-driven business models for sustainable success. Pharmaceutical transformation is essential for leveraging innovation in business models creates better products and services for an optimal patient and customer experience. It leverages three main capabilities:
Discovery capability to generate strategic insights encompassing the global ecosystem from the traditional scope to new business opportunities
Incubation capability to turn ideas into experimentation and accelerate the iterative learning curve from pilots to business initiatives
Acceleration capability to leverage business size to maximize the market fit
To manage their portfolio(s) of business models efficiently, pharmaceutical companies must address the following two scopes to create new strategic alternatives:
Exploitation of current business models with the ability to optimize and transform components to outperform in the short and midterm.
Exploration of new business models with the ability to generate disruption across traditional boundaries mainly through strategic partnerships driving pharmaceutical transformation forward
As a management and technology consultancy, we take a holistic approach to pharmaceutical business transformation, from strategy to implementation, embracing organization and governance, people and culture, processes and IT dimensions.
We support you in improving your current business model, providing benchmark insights. We can also help you develop and implement innovative concepts and assist you in their implementation. Our role is crucial in guiding life science transformation through tailored strategies and operational execution.
In the current efforts to reshape pharma organizations, we notice that exponential improvement is generated by three major building blocks: Data, Services and Platforms.

Data: from collection to generating insights, data provides strong value creation with a better decision-making process for better outcomes. At the pharma company level and for all healthcare landscape stakeholders, it empowers patients, physicians, regulators, payers, and industries.
Services: services must be anchored in the customer and patient journey. Once launched, service monitoring and iteration based on performance and customer feedback are crucial to success.
Platforms: healthcare platforms are starting to show the potential to improve patient care, prevention, diagnosis, treatment and aftercare. They should significantly increase services productivity and reduce costs down the line.
Working with life sciences companies, the healthcare and social sectors, insurance players, we have the capabilities to support you in designing and building these three main blocks through a collective intelligence approach.
The following are among many different assignments we have conducted:
Business Strategy
Organization
Innovation